Development of bone-targeted Ron inhibitors to treat osseous metastases from breast cancers

被引：0
|
作者：
Thode, Trason [1 ]
Fornetti, Jaime [2 ]
del Villar, Ryan Rodriguez [1 ]
Weston, Alexis [1 ]
Ng, Serina [1 ]
Dana, Srikanta [1 ]
Soldi, Raffaella [1 ]
Kaadige, Mohan [1 ]
Vankayalapati, Hariprasad [2 ]
Kasibhatla, Srinivas [1 ]
Welm, Alana [2 ]
Sharma, Sunil [1 ]
机构：
[1] Translat Genom Res Inst, Phoenix, AZ USA
[2] Huntsman Canc Inst, Salt Lake City, UT USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3948
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Guideline adherence in bone-targeted treatment of cancer patients with bone metastases in Germany
    Link, Hartmut
    Diel, Ingo
    Ohlmann, Carsten-H
    Holtmann, Laura
    Kerkmann, Markus
    SUPPORTIVE CARE IN CANCER, 2020, 28 (05) : 2175 - 2184
  • [22] Practical update for the use of bone-targeted agents in patients with bone metastases from metastatic breast cancer or castration-resistant prostate cancer
    Southcott, D.
    Awan, A.
    Ghate, K.
    Clemons, M.
    Fernandes, R.
    CURRENT ONCOLOGY, 2020, 27 (04) : 220 - 224
  • [23] Bone-targeted agents in the treatment of bone metastases: RANK outsider or new kid on the block?
    Bouganim, Nathaniel
    Clemons, Mark J.
    FUTURE ONCOLOGY, 2011, 7 (03) : 381 - 383
  • [24] Future directions of bone-targeted therapy for metastatic breast cancer
    Tomifumi Onishi
    Naoki Hayashi
    Richard L. Theriault
    Gabriel N. Hortobagyi
    Naoto T. Ueno
    Nature Reviews Clinical Oncology, 2010, 7 : 641 - 651
  • [25] Future directions of bone-targeted therapy for metastatic breast cancer
    Onishi, Tomifumi
    Hayashi, Naoki
    Theriault, Richard L.
    Hortobagyi, Gabriel N.
    Ueno, Naoto T.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (11) : 641 - 651
  • [26] weekly administration of bone-targeted agents (denosumab, zoledronate, or pamidronate) in patients with bone metastases from either breast or castration resistant prostate cancer.
    Clemons, Mark J.
    Ong, Michael
    Stober, Carol
    Ernst, D. Scott
    Booth, Christopher M.
    Canil, Christina M.
    Mates, Mihaela
    Robinson, Andrew George
    Blanchette, Phillip S.
    Joy, Anil Abraham
    Hilton, John Frederick
    Aseyev, Olexiy
    Pond, Gregory Russell
    Hutton, Brian
    Jeong, Ahwon
    Vandermeer, Lisa
    Fergusson, Dean
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] Bone-targeted engineered bacterial extracellular vesicles delivering miRNA to treat osteoporosis
    Liu H.
    Wu Y.
    Wang F.
    Wang S.
    Ji N.
    Wang M.
    Zhou G.
    Han R.
    Liu X.
    Weng W.
    Tan H.
    Jing Y.
    Zhang W.
    Zhang H.
    Shi Z.
    Su J.
    Composites Part B: Engineering, 2023, 267
  • [28] Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte Ratio
    Bongiovanni, Alberto
    Foca, Flavia
    Menis, Jessica
    Stucci, Stefania Luigia
    Artioli, Fabrizio
    Guadalupi, Valentina
    Forcignano, Maria Rosachiara
    Fantini, Manuela
    Recine, Federica
    Mercatali, Laura
    Spadazzi, Chiara
    Burgio, Marco Angelo
    Fausti, Valentina
    Miserocchi, Anna
    Ibrahim, Toni
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [29] PREOPERATIVE EMBOLIZATION OF OSSEOUS METASTASES FROM HYPERVASCULAR CANCERS
    MILLER, DL
    HAINES, GA
    JULIANO, PJ
    GHOSH, BC
    JOURNAL OF SURGICAL ONCOLOGY, 1995, 60 (02) : 133 - 134
  • [30] Side Effects of Bone-Targeted Therapies in Advanced Breast Cancer
    Domschke, Christoph
    Schuetz, Florian
    BREAST CARE, 2014, 9 (05) : 332 - 336
12345